Clinical Trial Update: Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso [Phase 1]

View source ↗

Summary

An open-label Phase 1 study evaluated the safety and tolerability of TreT in patients with pulmonary arterial hypertension who are currently using Tyvaso; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• TreT
• Tyvaso (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2024-11-01